• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮下植入式心脏复律除颤器的心电图入选标准:自行车运动期间的评估

Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise.

作者信息

Ziacchi Matteo, Corzani Alessandro, Diemberger Igor, Martignani Cristian, Marziali Alessandro, Mazzotti Andrea, Massaro Giulia, Rapezzi Claudio, Biffi Mauro, Boriani Giuseppe

机构信息

Institute of Cardiology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, S.Orsola-Malpighi University Hospital, Bologna, Italy.

Institute of Cardiology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna, S.Orsola-Malpighi University Hospital, Bologna, Italy.

出版信息

Heart Lung Circ. 2016 May;25(5):476-83. doi: 10.1016/j.hlc.2015.10.016. Epub 2015 Nov 18.

DOI:10.1016/j.hlc.2015.10.016
PMID:27044657
Abstract

BACKGROUND

The subcutaneous implantable cardioverter-defibrillator (S-ICD) is used in patients at risk of sudden death. Our aim was to assess clinical predictors of electrocardiographic ineligibility for S-ICD, and the impact of exercise on S-ICD eligibility in an unselected series of patients requiring ICD therapy.

METHODS

102 patients at risk of sudden death were evaluated at rest and during exercise. Electrocardiograph screening using limb lead electrodes (to simulate the S-ICD sensing vectors) was performed at rest and during bicycle ergometer exercise.

RESULTS

R wave amplitude in lead D3 during exercise >16mV, baseline QTc and the sum of amplitudes of the R waves at supine >30mV were predictors of ineligibility for S-ICD. Eligibility increased from 90% to 100% of patients when evaluated with an "any of the three leads" criterion compared to current recommendations. A more restrictive criterion based on two of three ECG leads caused an eligibility drop at 66%, that further decreased to 56% during exercise; these figures improved to 79% and 81%, respectively, when an "any 2 of 3 leads" criterion was used.

CONCLUSIONS

Huge ECG amplitude and QTc duration are associated with ineligibility in the current S-ICD release. By performing exercise testing, lead suitability changes in one patient out of 14 (7% of tested patients) and eligibility is decreased by use of a more stringent criterion for eligibility (ECG criteria satisfied in two of three leads). A dynamic selection of sensing vectors aiming at situation-specific suitability (any of three leads) would increase S-ICD eligibility to 100% of patients.

摘要

背景

皮下植入式心律转复除颤器(S-ICD)用于有猝死风险的患者。我们的目的是评估心电图不符合S-ICD植入标准的临床预测因素,以及运动对一系列未经选择的需要ICD治疗的患者中S-ICD植入资格的影响。

方法

对102例有猝死风险的患者在静息和运动期间进行评估。使用肢体导联电极(模拟S-ICD感知向量)在静息和自行车测力计运动期间进行心电图筛查。

结果

运动期间D3导联R波振幅>16mV、基线QTc以及仰卧位时R波振幅总和>30mV是不符合S-ICD植入标准的预测因素。与当前建议相比,采用“三根导联中的任何一根”标准评估时,患者的植入资格从90%提高到100%。基于三根心电图导联中的两根的更严格标准导致植入资格降至66%,运动期间进一步降至56%;当使用“三根导联中的任意两根”标准时,这些数字分别提高到79%和81%。

结论

巨大的心电图振幅和QTc持续时间与当前S-ICD版本的植入不合格相关。通过进行运动测试,14名患者中有1名(占测试患者的7%)的导联适用性发生变化,并且使用更严格的植入标准(三根导联中的两根满足心电图标准)会降低植入资格。针对特定情况的适用性(三根导联中的任何一根)动态选择感知向量将使100%的患者符合S-ICD植入资格。

相似文献

1
Electrocardiographic Eligibility for Subcutaneous Implantable Cardioverter Defibrillator: Evaluation during Bicycle Exercise.皮下植入式心脏复律除颤器的心电图入选标准:自行车运动期间的评估
Heart Lung Circ. 2016 May;25(5):476-83. doi: 10.1016/j.hlc.2015.10.016. Epub 2015 Nov 18.
2
Exercise stress test reveals ineligibility for subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.运动负荷试验显示,布加综合征患者不适合植入皮下植入式心律转复除颤器。
J Cardiovasc Electrophysiol. 2017 Dec;28(12):1454-1459. doi: 10.1111/jce.13315. Epub 2017 Sep 1.
3
How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation?有多少患者符合皮下植入式心律转复除颤器植入的体表心电图标准?
Europace. 2014 Jul;16(7):1015-21. doi: 10.1093/europace/eut370. Epub 2013 Dec 18.
4
Use of an electrocardiographic screening tool to determine candidacy for a subcutaneous implantable cardioverter-defibrillator.使用心电图筛查工具来确定皮下植入式心律转复除颤器的适用对象。
Heart Rhythm. 2014 Aug;11(8):1361-6. doi: 10.1016/j.hrthm.2014.04.025. Epub 2014 Apr 19.
5
The utility of routine clinical 12-lead ECG in assessing eligibility for subcutaneous implantable cardioverter defibrillator.常规临床 12 导联心电图在评估是否适合植入皮下植入式心律转复除颤器中的应用。
Comput Biol Med. 2018 Nov 1;102:242-250. doi: 10.1016/j.compbiomed.2018.05.002. Epub 2018 May 8.
6
Prevalence of subcutaneous implantable cardioverter-defibrillator based on template ECG screening and ineligible surface ECG predicting factors in patients with hypertrophic cardiomyopathy in China.基于模板心电图筛查的皮下植入式心律转复除颤器在中国肥厚型心肌病患者中的患病率及不合格体表心电图预测因素
Heart Vessels. 2019 May;34(5):851-859. doi: 10.1007/s00380-018-1300-8. Epub 2018 Nov 21.
7
Prevalence of subcutaneous implantable cardioverter-defibrillator candidacy based on template ECG screening in patients with hypertrophic cardiomyopathy.基于模板心电图筛查肥厚型心肌病患者皮下植入式心脏复律除颤器候选者的患病率。
Heart Rhythm. 2016 Feb;13(2):457-63. doi: 10.1016/j.hrthm.2015.09.007. Epub 2015 Sep 8.
8
Eligibility for subcutaneous implantable cardioverter-defibrillator in congenital heart disease.先天性心脏病患者植入皮下植入式心律转复除颤器的适应证
Heart Rhythm. 2020 May;17(5 Pt B):860-869. doi: 10.1016/j.hrthm.2020.01.016.
9
Predictors of electrocardiographic screening failure for the subcutaneous implantable cardioverter-defibrillator in children: A prospective multicenter study.儿童皮下植入式心律转复除颤器心电图筛查失败的预测因素:一项前瞻性多中心研究。
Heart Rhythm. 2018 May;15(5):703-707. doi: 10.1016/j.hrthm.2018.01.004. Epub 2018 Jan 5.
10
Subcutaneous implantable cardioverter defibrillator eligibility according to a novel automated screening tool and agreement with the standard manual electrocardiographic morphology tool.根据一种新型自动筛查工具评估皮下植入式心律转复除颤器的适用性以及与标准手动心电图形态学工具的一致性。
J Interv Card Electrophysiol. 2018 Jun;52(1):61-67. doi: 10.1007/s10840-018-0326-2. Epub 2018 Mar 3.

引用本文的文献

1
Subcutaneous Implantable Cardioverter Defibrillator: A Contemporary Overview.皮下植入式心律转复除颤器:当代概述。
Life (Basel). 2023 Jul 28;13(8):1652. doi: 10.3390/life13081652.
2
Vector configuration screening failure after defibrillation threshold testing: Should we be concerned?除颤阈值测试后向量配置筛选失败:我们应该担心吗?
HeartRhythm Case Rep. 2023 Mar 30;9(6):401-405. doi: 10.1016/j.hrcr.2023.03.015. eCollection 2023 Jun.
3
Association Between Subcutaneous Implantable Cardioverter Defibrillator Preimplantation Screening and the Response to Cardiac Resynchronization Therapy.
皮下植入式心脏复律除颤器植入前筛查与心脏再同步治疗反应之间的关联
Korean Circ J. 2020 Dec;50(12):1062-1073. doi: 10.4070/kcj.2019.0420. Epub 2020 Oct 7.
4
Subcutaneous implantable cardioverter defibrillator eligibility according to a novel automated screening tool and agreement with the standard manual electrocardiographic morphology tool.根据一种新型自动筛查工具评估皮下植入式心律转复除颤器的适用性以及与标准手动心电图形态学工具的一致性。
J Interv Card Electrophysiol. 2018 Jun;52(1):61-67. doi: 10.1007/s10840-018-0326-2. Epub 2018 Mar 3.
5
Analysis of Screening Electrocardiogram for the Subcutaneous Defibrillator in Adults with Congenital Heart Disease.先天性心脏病成人皮下除颤器筛查心电图分析
Pediatr Cardiol. 2017 Aug;38(6):1162-1168. doi: 10.1007/s00246-017-1635-4. Epub 2017 May 22.